Viewing StudyNCT02996396



Ignite Creation Date: 2024-05-06 @ 9:30 AM
Last Modification Date: 2024-10-26 @ 12:15 PM
Study NCT ID: NCT02996396
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-06-07
First Post: 2016-12-12

Brief Title: Nellix Registry Study EVAS-Global
Sponsor:
Organization: Endologix

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: True
Target Duration: 60 Months
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 300
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
38660
Who Masked List: